Paul-Flechsig-Institut für Hirnforschung
 Universitätsmedizin Leipzig

biomarker:

Development of enrichment protocols and new selective assays for misfolded tau protein

Mainstay of laboratory diagnostics of neurodegenerative diseases is the confirmation of clinical diagnosis of Alzheimers disease (AD) and its separation from other forms of dementia. Artikel lesen
 
 

Lymphocyte activation test as blood biomarker for Alzheimer's disease

It is the aim of the project to validate a blood biomarker for the diagnosis of Alzheimer´s disease (AD) as an inexpensive and non-invasive tool which can easily be performed on a large scale at the primary care level and allows to identify patients with high sensitivity at initial stage of AD with mild dementia. Artikel lesen
 
 
 
last update: 12.06.2018, 13:28 Uhr
Zurück zum Seitenanfang springen
Zurück zum Seitenanfang springen
Paul-Flechsig-Institut für Hirnforschung